Portal de Periódicos da CAPES

ANTIFUNGAL THERAPY IN ‘BONE MARROW FAILURE’

1998; Wiley; Volume: 100; Issue: 4 Linguagem: Inglês

10.1046/j.1365-2141.1998.00600.x

1365-2141

Malcolm Richardson, M Kokki,

Antifungal resistance and susceptibility

British Journal of HaematologyVolume 100, Issue 4 p. 619-628 ANTIFUNGAL THERAPY IN 'BONE MARROW FAILURE' Malcolm D. Richardson, Malcolm D. Richardson Regional Mycology, Reference Laboratory, Department of Dermatology, University of Glasgow and West Glasgow Hospitals University NHS Trust, Glasgow, U.K.,Search for more papers by this authorMaarit H. Kokki, Maarit H. Kokki National Public Health Institute, Helsinki, FinlandSearch for more papers by this author Malcolm D. Richardson, Malcolm D. Richardson Regional Mycology, Reference Laboratory, Department of Dermatology, University of Glasgow and West Glasgow Hospitals University NHS Trust, Glasgow, U.K.,Search for more papers by this authorMaarit H. Kokki, Maarit H. Kokki National Public Health Institute, Helsinki, FinlandSearch for more papers by this author First published: 25 December 2001 https://doi.org/10.1046/j.1365-2141.1998.00600.xCitations: 38 Dr Richardson Regional Mycology Reference Laboratory, Department of Dermatology, Robertson Building, University of Glasgow, 56 Dumbarton Road, Glasgow G11 6NU. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Annaissie, E.J., Vartivarian, S.E., Abu-Said, D., Uzon, O., Pinczowsi, H., Kontoyiannis, D.P., Khoury, P., Papadakis, K., Gardner, A., Raad, I.I., Gilbreath, J., Bodey, G.P. (1996) Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study. American Journal of Medicine, 101, 170 176. 10.1016/S0002-9343(96)80072-6 PubMedWeb of Science®Google Scholar 2 Anttila, V-J., Elonen, E., Nordling, S., Sivonen, A., Ruutu, T., Ruutu, P. (1997a) Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications. Clinical Infectious Diseases, 24, 375 380. 10.1093/clinids/24.3.375 PubMedWeb of Science®Google Scholar 3 Anttila, V.-J., Farkkila, M., Jansson, S.E., Taavitsainen, M., Kaukoranta-Tolvanen, S.-S., Nordling, S., Koukila-Kahkola, P., Ruutu, T., Ruutu, P. (1997b) Diagnostic laparoscopy in patients with acute leukemia and suspected hepatic candidiasis. European Journal of Clinical Microbiology and Infectious Diseases, 16, 637 643. 10.1007/BF01708552 CASPubMedWeb of Science®Google Scholar 4 Anttila, V-J., Ruutu, P., Bondestam, S., Jansson, S.-E., Nordling, S., Farkkila, M., Sivonen, A., Castren, M., Ruutu, T. (1994) Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem. Clinical Infectious Diseases, 18, 979 981. 10.1093/clinids/18.6.979 CASPubMedWeb of Science®Google Scholar 5 Beyer, J., Barzen, G., Risse, G., Weyer, C., Miksits, K., Dullenkopf, K., Huhn, D., Siegert, W. (1994a) Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis. Antimicrobial Agents and Chemotherapy, 37, 1367 1369. 10.1128/AAC.37.6.1367 Web of Science®Google Scholar 6 Beyer, J., Schwartz, S., Heinemann, V., Wolfgang, S. (1994b) Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients. Antimicrobial Agents and Chemotherapy, 38, 911 917. 10.1128/AAC.38.5.911 PubMedWeb of Science®Google Scholar 7 Bodey, G.P., Anaissie, E., Gutterman, J., Vadhan-Raj, S. (1993) Role of granulocyte-macrophage colony-stimulating factor as adjuvant treatment in neutropenic patients with bacterial and fungal infection. European Journal of Clinical Microbiology and Infectious Diseases, 13, 18 22. 10.1007/BF01973597 Web of Science®Google Scholar 8 Bohme, A. & Hoelzer, D. (1996) Liposomal amphotericin B as early empiric antimycotic therapy of pneumonia in granulocytopenic patients. Mycoses, 39, 419 426. 10.1111/j.1439-0507.1996.tb00090.x CASPubMedWeb of Science®Google Scholar 9 Bow, E.J., Loewen, R., Cheang, M.S., Schacter, B. (1995) Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukaemia: the pathogenic role of the antileukaemic regimen. Clinical Infectious Diseases, 21, 361 369. 10.1093/clinids/21.2.361 PubMedWeb of Science®Google Scholar 10 Caillot, D., Casasnovas, O., Bernard, A., Couaillier, J.F., Durand, C., Cuisenier, B., Solary, E., Piard, F., Petrella, T., Bonnin, A., Couillault, G., Dumas, M., Guy, H. (1997) Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. Journal of Clinical Oncology, 15, 139 147. 10.1200/JCO.1997.15.1.139 CASPubMedWeb of Science®Google Scholar 11 Castagnola, E., Bucci, B., Montinaro, E., Viscoli, C. (1996) Fungal infections in patients undergoing bone marrow transplantation: an approach to a rational management protocol. Bone Marrow Transplantation, 18, (Suppl. 2), 97 106. PubMedWeb of Science®Google Scholar 12 Chanock, S.J. & Walsh, T.J. (1996) Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients. Bone Marrow Transplantation, 18, (Suppl. 3), S15 S20. PubMedWeb of Science®Google Scholar 13 Chanock, S.J. & Walsh, T.J. (1997) Molecular diagnosis of Candida infection in the compromised host: current status and future prospects. International Journal of Infectious Diseases, 1, (Suppl. 1), S20 S24. Google Scholar 14 Chopra, R., Fielding, A., Goldstone, A.H. (1992) Successful treatment of fungal infections in neutropenic patients with liposomal amphotericin (AmBisome): a report on 40 cases from a single center. Leukemia and Lymphoma, 7, 73 77. 10.3109/10428199209061570 PubMedWeb of Science®Google Scholar 15 D'Antonio, D., Lacone, A., Schioppa, F.S., Bonfini, T., Romano, F. (1996) Effect of the current antimicrobial therapeutic strategy on fungal colonization in patients with hematologic malignancies. Current Microbiology, 33, 118 122. 10.1007/s002849900085 CASPubMedWeb of Science®Google Scholar 16 Denning, D.W. (1994) Treatment of invasive aspergillosis. Journal of Infection, 28, (Suppl. 1), 25 29. 10.1016/S0163-4453(94)95941-2 PubMedWeb of Science®Google Scholar 17 Denning, D.W., Evans, E.G.V., Kibbler, C.C., Richardson, M.D., Roberts, M.M., Rogers, T.R., Warnock, D.W., Warren, R.E. (1997) Guidelines for the investigation of invasive fungal infections in haematological malignancy and solid organ transplantation. European Journal of Microbiology and Infectious Diseases, 16, 424 436. 10.1007/BF02471906 CASPubMedWeb of Science®Google Scholar 18 Denning, D.W. & Stevens, D.A. (1990) Antifungal and surgical treatment of invasive aspergillosis: review of 2121 published cases. Reviews in Infectious Diseases, 12, 1147 1158. 10.1093/clinids/12.6.1147 CASPubMedWeb of Science®Google Scholar 19 Edwards, J.E., Bodey, G.P., Bowden, R.A., Buchner, T., De Pauw, B.E., Filler, S.G., Ghannoum, M.A., Glauser, M., Herbrecht, R., Kauffman, C.A., Kohno, S., Martino, P., Meunier, F., Mori, T., Pfaller, M.A., Rex, J.H., Rogers, T.R., Rubin, R.H., Solomkin, J., Viscoli, C., Walsh, T.J., White, M. (1997) International conference for the development of a consensus on the management and prevention of severe candidal infections. Clinical Infectious Diseases, 25, 43 59. 10.1086/514504 PubMedWeb of Science®Google Scholar 20 Franklin, I.M., Mehta, J., Root, T. (1997) The use of amphotericin B lipid complex. Journal of Antimicrobial Chemotherapy, 39, 288 290. 10.1093/jac/39.2.288 CASPubMedWeb of Science®Google Scholar 21 Fraser, I.S. & Denning, D.W. (1993) Empiric amphotericin B therapy: the need for a reappraisal. Blood Reviews, 7, 208 214. 10.1016/0268-960X(93)90007-Q CASPubMedWeb of Science®Google Scholar 22 Graham, N.J., Muller, N.L., Miller, R.R., Shepherd, J.D. (1991) Intrathoracic complications following allogeneic bone marrow transplantation: CT findings. Radiology, 181, 153 156. 10.1148/radiology.181.1.1887025 CASPubMedWeb of Science®Google Scholar 23 Granena, A., Carreras, E., Rozman, C., Salgado, C., Sierra, J., Algara, M., Rovira, M., Valls, A. (1993) Interstitial pneumonitis after bone marrow trransplantation: 15 years experience in a single institution. Bone Marrow Transplantation, 11, 453 458. CASPubMedWeb of Science®Google Scholar 24 Guoit, H.F.L., Fibbe, W.E., Van't Wout, J.W. (1994) Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clinical Infectious Diseases, 18, 525 532. 10.1093/clinids/18.4.525 PubMedWeb of Science®Google Scholar 25 Hillery, A.M. (1997) Supramolecular lipidic drug delivery systems: from laboratory to clinic: a review of the recently introduced commercial liposomal and lipid-based formulations of amphotericin B. Advanced Drug Delivery Reviews, 24, 345 363. 10.1016/S0169-409X(96)00496-6 CASWeb of Science®Google Scholar 26 Hoover, M., Morgan, E.R., Kletzel, M. (1997) Prior fungal infection is not a contraindication to bone marrow transplant in patients with acute leukemia. Medical and Pediatric Oncology, 28, 268 273. 10.1002/(SICI)1096-911X(199704)28:4 3.0.CO;2-G PubMedWeb of Science®Google Scholar 27 Hoppe, J.E., Klingebiel, T., Niethammer, D. (1994) Orointestinal yeast colonization of paediatric bone marrow transplant recipients: surveillance by quantitative culture and serology. Mycoses, 38, 51 57. 10.1111/j.1439-0507.1995.tb00008.x Web of Science®Google Scholar 28 Iwen, P.C., Reed, E.C., Armitage, J.O., Bierman, P.J., Kessinger, A., Vose, J.M., Arneson, M.A., Winfield, B.A., Woods, G.L. (1993) Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants. Journal of Infection Control and Hospital Epidemiology, 14, 131 137. 10.2307/30148476 CASPubMedWeb of Science®Google Scholar 29 Jantunen, E., Ruutu, P., Niskanen, L., Volin, L., Parkkali, T., Koukila-Kahkola, P., Ruutu, T. (1997) Incidence and risk factors for invasive fungal infections in allogeneic bone marrow transplant recipients. Bone Marrow Transplantation, 19, 801 808. 10.1038/sj.bmt.1700737 CASPubMedWeb of Science®Google Scholar 30 Jennings, T.S. & Hardin, T.C. (1993) Treatment of aspergillosis with itraconazole. Annals of Pharmacotherapy, 27, 1206 1209. 10.1177/106002809302701011 CASPubMedWeb of Science®Google Scholar 31 Karp, J.E., Merz, W.G., Dick, J.D. (1994) Management of infections in neutropenic patients: new opportunities and emerging challenges. Current Opinion in Infectious Diseases, 7, 430 435. 10.1097/00001432-199408000-00003 Web of Science®Google Scholar 32 Kato, Y.K., Hoshi, Y., Akatsuka, J., Suzuki, M. (1995) The effects of antifungal chemoprophylaxis and empiric therapy on invasive fungal infection in neutropenic children with malignant neoplasms. Pediatric Hematology and Oncology, 12, 1 18. 10.3109/08880019509029523 CASPubMedWeb of Science®Google Scholar 33 Kennedy, C.A., Adams, G.L., Neglia, J.P., Giebink, G.S. (1997) Impact of surgical treatment on paranasal fungal infections in bone marrow transplant patients. Otolaryngology: Head and Neck Surgery, 116, 610 616. 10.1016/S0194-5998(97)70236-5 CASPubMedWeb of Science®Google Scholar 34 Kibbler, C.C. (1995) Neutropenic infections: strategies for empirical therapy. Journal of Antimicrobial Chemotherapy, 36, (Suppl. B), 107 117. 10.1093/jac/36.suppl_B.107 PubMedWeb of Science®Google Scholar 35 Klastersky, J. (1995) Prevention and therapy of fungal infections in cancer patients: a review of recently published information. Support Care Cancer, 3, 393 401. 10.1007/BF00364979 CASPubMedWeb of Science®Google Scholar 36 LaRocco, M.T. & Burgert, S.J. (1997) Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation. Clinical Microbiology Reviews, 10, 277 297. 10.1128/CMR.10.2.277 CASPubMedWeb of Science®Google Scholar 37 Lister, J. (1996) Amphotericin B lipid complex (Abelcet®) in the treatment of invasive mycoses: the North American experience. European Journal of Haematology, 56, (Suppl. 57), 18 23. 10.1111/j.1600-0609.1996.tb01348.x Web of Science®Google Scholar 38 Loo, V.G., Bertrand, C., Dixon C., Vitye, D., DeSalis, B., McLean, A.P.H., Brox, A., Robson, H.G. (1996) Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit. Infection Control and Hospital Epidemiology, 17, 360 364. CASPubMedWeb of Science®Google Scholar 39 Lyytikainen, O., Ruutu, T., Volin, L., Lautenschlager, I., Jokipii, L., Tittanen, L., Ruutu, P. (1996) Late onset Pneumocystis carinii pneumonia following allogeneic bone marrow transplantation. Bone Marrow Transplantation, 17, 1057 1059. CASPubMedWeb of Science®Google Scholar 40 Martino, P. & Girmenia, C. (1996) Treatment of fungal infections in neutropenic patients. Revista Iberoamerican de Micologia, 13, S78 S81. Google Scholar 41 Martino, P., Girmenia, C., Micozzi, A., De Bernardis, F., Boccanera, M., Cassone, A. (1994) Prospective study of Candida colonization, use of empiric amphotericin B and development of invasive mycosis in neutropenic patients. European Journal of Microbiology and Infectious Diseases, 13, 797 804. 10.1007/BF02111339 CASPubMedWeb of Science®Google Scholar 42 Mehta, J., Chu, P., Powles, R., Kelsey, S. (1997) Amphotericin B lipid complex for the treatment of presumed or confirmed fungal infections in immunocompromised patients with hematologic malignancies. Bone Marrow Transplantation, 20, 39 43. 10.1038/sj.bmt.1700842 CASPubMedWeb of Science®Google Scholar 43 Mills, W., Chopra, R., Linch, D.C., Goldstone, A.H. (1994) Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients. British Journal of Haematology, 86, 754 759. 10.1111/j.1365-2141.1994.tb04825.x CASPubMedWeb of Science®Google Scholar 44 Ng, T.T.C. & Denning, D.W. (1995) Liposomal amphotericin B (AmBisome) therapy in invasive fungal infections: evaluation of United Kingdom compassionate use data. Annals of Internal Medicine, 155, 1093 1098. 10.1001/archinte.155.10.1093 PubMedWeb of Science®Google Scholar 45 Oppenheim, B.A., Herbrecht, R., Kusne, S. (1995) The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses. Clinical Infectious Diseases, 21, 1145 1153. 10.1093/clinids/21.5.1145 CASPubMedWeb of Science®Google Scholar 46 Oravcová, E., Mistrik, M., Sakalová, A., Drgoña, L., Kollár, T., Helpianska, L., Ilavasá, I., Sorkovaká, D., Spánik, S., Kukucková, E. (1995) Amphotericin B lipid complex to treat invasive fungal infections in cancer patients: report of efficacy and safety in 20 patients. Chemotherapy, 41, 473 476. 10.1159/000239385 CASPubMedWeb of Science®Google Scholar 47 Patterson, J.E., Zidouh, A., Miniter, P., Andriole, V.T., Patterson, T. (1997) Hospital epidemiologic surveillance for invasive aspergillosis: patient demographics and the utility of antigen detection. Infection Control and Hospital Epidemiology, 18, 104 108. CASPubMedWeb of Science®Google Scholar 48 Persat, F., Marzullo, C., Guyotat, D., Rochet, M.-J., Piens, M-A. (1992) Plasma itraconazole concentrations in neutropenic patients after repeated high-dose treatment. European Journal of Cancer, 28A, 838 841. 10.1016/0959-8049(92)90127-N CASPubMedWeb of Science®Google Scholar 49 Philpott-Howard, J. (1996) Prophylaxis and therapy of infections in neutropenic patients. Current Opinion in Infectious Diseases, 9, 218 222. 10.1097/00001432-199608000-00002 Web of Science®Google Scholar 50 Pizzo, P.A. (1993) Management of fever in patients with cancer and treatment-induced neutropenia. New England Journal of Medicine, 328, 1323 1332. 10.1056/NEJM199305063281808 CASPubMedWeb of Science®Google Scholar 51 Poirier, J.M., Berlioz, F., Isnard, F., Cheymol, G. (1996) Marked intra- and inter-patient variability of itraconazole steady state plasma concentrations. Therapie, 51, 163 167. CASPubMedWeb of Science®Google Scholar 52 Prentice, H.G., Hann, I.M., Herbrecht, R., Aoun, M., Kvaloy, S., Catovsky, D., Pinkerton, C.R., Schey, S.A., Jacobs, F., Oakhill, A., Stevens, S.A., Darbyshire, P.J., Gibson, B.E.S. (1997) A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients. British Journal of Haematology, 98, 711 718. 10.1046/j.1365-2141.1997.2473063.x CASPubMedWeb of Science®Google Scholar 53 Ribaud, P. (1997) Fungal infections and the cancer patient. European Journal of Cancer, 33, (Suppl. 4), S50 S54. 10.1016/S0959-8049(97)00150-0 PubMedWeb of Science®Google Scholar 54 Ribaud, P. & Gluckman, E. (1996) Critical review of lipid amphotericin B formulations as treatment of invasive aspergillosis in patients with hematological disorders or bone marrow transplantation (BMT). Journal de Mycologie Medicale, 6, (Suppl. 1), 17 20. Google Scholar 55 Ringden, O., Meunier, F., Tollemar, J., Ricci, P., Tura, S., Kuse, E., Viviani, M.A., Gorin, N.C., Klastersky, J., Fenaux, P., Prentice, H.G., Ksionski, G. (1991) Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in treatment of invasive fungal infections in immunocompromised patients. Journal of Antimicrobial Chemotherapy, 28, (Suppl. B), 73 82. 10.1093/jac/28.suppl_B.73 PubMedWeb of Science®Google Scholar 56 Schaffner, A. (1994) Prophylaxis and treatment of fungal infections in cancer patients. Bailliere's Clinical Infectious Diseases, 1, 499 522. Web of Science®Google Scholar 57 Tollemar, J. & Ringden, O. (1995) Lipid formulations of amphotericin B: less toxicity but at what economic cost? Drug Safety, 13, 207 214. 10.2165/00002018-199513040-00001 CASPubMedWeb of Science®Google Scholar 58 Toren, A., Or, R., Ackerstein, A., Nagler, A. (1997) Invasive fungal infections in lymphoma patients receiving immunotherapy following autologous bone marrow transplantation (ABMT). Bone Marrow Transplantation, 20, 67 69. 10.1038/sj.bmt.1700847 CASPubMedWeb of Science®Google Scholar 59 Tumbarello, M., Tacconelli, E., Pagano, L., Ortu La Barbera, E., Morace, G., Cauda, R., Leone, G., Ortona, L. (1997) Comparative analysis of prognostic indicators of aspergillosis in haematological malignancies and HIV infection. Journal of Infection, 34, 55 60. 10.1016/S0163-4453(97)80010-2 CASPubMedWeb of Science®Google Scholar 60 Viscoli, C., Castagnola, E., Van Lint, M.T., Moroni, C., Garaventa, A., Rossi, M.R., Fanci, R., Menichetti, F., Caselli, D., Giacchino, M., Congin, M. (1996) Fluconazole versus amphotericin B as empirical antifungal therapy of unexplained fever in granulocytopenic cancer patients: a pragmatic, multicentre, prospective and randomised clinical trial. European Journal of Cancer, 32A, 814 820. 10.1016/0959-8049(95)00619-2 CASPubMedWeb of Science®Google Scholar 61 Wald, A., Leisenring, W., Van Burik, J-A., Bowden, R.A. (1997) Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. Journal of Infectious Diseases, 175, 1459 1466. 10.1086/516480 PubMedWeb of Science®Google Scholar 62 Walsh, T.J. & Chanock, S.J. (1997) Laboratory diagnosis of invasive candidiasis: a rationale for complementary use of culture- and nonculture-based detection systems. International Journal of Infectious Diseases, 1, (Suppl. 1), S11 S19. Google Scholar 63 Walsh, T.J., Hiemenz, J.W., Anaissie, E. (1996) Recent progress and current problems in treatment of invasive fungal fungal infections in neutropenic patients. Infectious Disease Clinics of North America, 10, 365 400. 10.1016/S0891-5520(05)70303-2 PubMedWeb of Science®Google Scholar 64 Walsh, T.J., Bodensteiner, D., Hiemenz, J.W., Thaler, S., Greenberg, R., Arndt, C., Holcenberg, J., Schwartz, C., Pappas, P., Dummer, S., Marsh, R., Schuster, M., Seibel, N., and The Mycoses Study Group (MSG), Empirical Antifungal Study Group (1997) A randomized, double-blind trial of AmBisome (liposomal amphotericin B) versus amphotericin B in the empirical treatment of persistently febrile neutropenic patients. Abstracts of the 37th ICAAC, Toronto, LM-90. Google Scholar 65 White, M.H., Anaissie, E.J., Kusne, S., Wingard, J.R., Hiemenz, J.W., Cantor, A., Gurwith, M., Du Mond, C., Mamelok, R.D., Bowden, R.A. (1997) Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis. Clinical Infectious Diseases, 24, 635 642. CASPubMedWeb of Science®Google Scholar 66 Yuen, K.-Y., Woo, P.C.Y., Ip, M.S.M., Liang, R.H.S., Chiu, E.K.W., Siau, H., Ho, P.K., Chen, F.F.E., Chan, T-K. (1997) Stage-specific manifestations of mould infections in bone marrow transplant recipients: risk factors and clinical significance of positive concentrated smears. Clinical Infectious Diseases, 25, 37 42. 10.1086/514492 CASPubMedWeb of Science®Google Scholar Citing Literature Volume100, Issue4March 1998Pages 619-628 ReferencesRelatedInformation